Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-18-018272
Filing Date
2018-03-16
Accepted
2018-03-16 16:03:06
Documents
5
Effectiveness Date
2018-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 a18-8369_1s8.htm S-8 115167
2 EX-5.1 a18-8369_1ex5d1.htm EX-5.1 12671
3 EX-23.2 a18-8369_1ex23d2.htm EX-23.2 3756
4 GRAPHIC g83691kmi001.jpg GRAPHIC 1252
5 GRAPHIC g83691kmi002.jpg GRAPHIC 1401
  Complete submission text file 0001104659-18-018272.txt   136589
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223721 | Film No.: 18695612
SIC: 2834 Pharmaceutical Preparations